Changes in clinical trials of cancer drugs in mainland China over the decade 2009–18: a systematic review by Li, Ning, Prof, Huang, Hui-Yao, PhD, Wu, Da-Wei, MD, Yang, Zhi-Min, Prof, Wang, Jun, Prof, Wang, Jian-Sheng, Prof, Wang, Shu-Hang, MD, Fang, Hong, MPharm, Yu, Yue, MD, Bai, Ying, MN, Yan, Zhao, Prof, Cao, Ye, PhD, Jiang, Min, MPharm, Liu, Yan-Fei, MN, Li, Kun-Yan, PhD, Xu, Bing-He, Prof, Sun, Yan, Prof, He, Jie, Prof

Get full text

Accelerating the integration of China into the global development of innovative anticancer drugs by Huang, Huiyao, Prof, Wu, Dawei, MD, Miao, Huilei, MD, Tang, Yu, Prof, Liu, Chengcheng, PhD, Fang, Hong, MPharm, Meng, Xinyu, MBIOS, Wang, Shuhang, Prof, Zhu, Qi, MPharm, Wang, Xin, Prof, Du, Jingting, MPharm, Yang, Zhimin, Prof, Li, Ning, Prof, Xu, Binghe, Prof, He, Jie, Prof

Get full text